ClinVar Miner

Submissions for variant NM_001080467.3(MYO5B):c.946G>A (p.Gly316Arg)

gnomAD frequency: 0.00003  dbSNP: rs753558336
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000289007 SCV000409026 uncertain significance Congenital microvillous atrophy 2017-04-27 criteria provided, single submitter clinical testing The MYO5B c.946G>A (p.Gly316Arg) variant has been reported in a single study in which it was found in a homozygous state in one individual diagnosed with diarrhea with microvillus atrophy (Szperl et al. 2011). The variant was absent from 50 ethnically matched control individuals and is reported at a frequency of 0.00095 in the Latino population of the Exome Aggregation Consortium. The variant results in a substitution of a small aliphatic residue with a large charged arginine and affects residues localized in critical regions of the motor domain which is important for allosteric rearrangements (van der Velde et al. 2013). The evidence for this variant is limited. The p.Gly316Arg variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for diarrhea with microvillus atrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Revvity Omics, Revvity RCV003137929 SCV003817829 uncertain significance not provided 2021-08-30 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003418034 SCV004113097 uncertain significance MYO5B-related disorder 2022-11-18 criteria provided, single submitter clinical testing The MYO5B c.946G>A variant is predicted to result in the amino acid substitution p.Gly316Arg. This variant was reported in the homozygous state in an individual with microvillus inclusion disease and in an individual with IPEX (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked)-like syndrome (Szperl et al 2011. PubMed ID: 21206382; Baxter SK et al 2021. PubMed ID: 33864888). This variant is reported in 0.037% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-47511088-C-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV000289007 SCV004805027 pathogenic Congenital microvillous atrophy 2024-03-17 criteria provided, single submitter research
GeneDx RCV003137929 SCV005080219 uncertain significance not provided 2023-12-07 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 21206382, 24014347, 33864888)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.